CompoAtlas

Herbaton Gan Mao Lin Tablet

Herbaton Gan Mao Lin Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL13045034T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
WINWA MEDICAL SDN. BHD.
Manufacturer
WINWA MEDICAL SDN. BHD.
Registration period starting
2023-05-01
Published validity end
2028-05-01

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Lonicera japonicaLonicera japonica[84mg;720mg]Not identified
Forsythia suspensaForsythia suspensa[84mg;720mg]Not identified
Arctium lappaArctium lappa[84mg;720mg]Not identified
SOJAE PRAEPARATUMSOJAE PRAEPARATUM[70mg;720mg]Not identified
Phragmites communisPhragmites communis[70mg;720mg]Not identified
Platycodon grandiflorumPlatycodon grandiflorum[35mg;720mg]Not identified
Schizonepeta tenuifoliaSchizonepeta tenuifolia[35mg;720mg]Not identified
Lophatherum gracileLophatherum gracile[35mg;720mg]Not identified
Gypsum fibrosumGypsum fibrosum[20mg;720mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Lonicera japonica[84mg;720mg],Forsythia suspensa[84mg;720mg],Arctium lappa[84mg;720mg],SOJAE PRAEPARATUM[70mg;720mg],Phragmites communis[70mg;720mg],Platycodon grandiflorum[35mg;720mg],Schizonepeta tenuifolia[35mg;720mg],Lophatherum gracile[35mg;720mg],Gypsum fibrosum[20mg;720mg]
Valid until
2028-05-01
Registration date
2023-05-01
Published description
NATURAL PRODUCT
Licence holder
WINWA MEDICAL SDN. BHD.
Producer
WINWA MEDICAL SDN. BHD.
Published name
Herbaton Gan Mao Lin Tablet
Published reference
201210302017T
Registration number
MAL13045034T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL13045034T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Arctium lappa
    Read the warning, when it applies and the studies cited

    Burdock - Arctium Lappa - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Barnes et al. 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

    BURDOCK - ARCTIUM LAPPA - Topical

    Cautions and warnings

    For external use only.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Barnes 2007).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with eyes and mucous membranes. If contact occurs, rinse thoroughly with water.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line